Featured Research

from universities, journals, and other organizations

B-Cell Lymphoma Protected By SPAK Silencing

Date:
October 10, 2009
Source:
American Journal of Pathology
Summary:
Scientists have demonstrated that misregulation of the protein SPAK may contribute to B-cell lymphoma development.

A group led by Dr. Michael Teitell at UCLA has demonstrated that misregulation of the protein SPAK may contribute to B-cell lymphoma development.

B-cell lymphomas are the most frequent human immune system cancers. Epigenetic changes, such as DNA hypermethylation, may promote B-cell transformation by silencing tumor suppressor genes.

Expression levels SPAK, a protein that regulates cellular stress responses, are reduced during cancer progression. Using a mouse model of B-cell malignancies and human B-cell lymphoma tissue samples, Balatoni et al report that SPAK expression is inhibited in B-cell tumors due in part to hypermethylation. Decreased SPAK expression protected B cells from environmental stressors that would induce cell death in non-cancerous cells. This SPAK-silenced protection may therefore be responsible for survival and metastatic progression in DNA-damaged B cells.

Dr. Teitell and colleagues suggest "that SPAK silencing in B-cell lymphomas promotes cancer progression by crippling genotoxic stress signaling to impair caspase activation. These results likely generalize to breast, prostate, and possibly other cancers beyond B lymphoma and uncover a novel role for SPAK in controlling the DNA damage response, highlighting a protective cell death mechanism that is disabled during the progression of cancer. SPAK expression or repression may also help indicate those patient tumors that should or should not receive genotoxic therapies as the development of personalized medicine pushes ahead."


Story Source:

The above story is based on materials provided by American Journal of Pathology. Note: Materials may be edited for content and length.


Journal Reference:

  1. Balatoni et al. Epigenetic Silencing of Stk39 in B-Cell Lymphoma Inhibits Apoptosis from Genotoxic Stress. American Journal Of Pathology, 2009; 175 (4): 1653 DOI: 10.2353/ajpath.2009.090091

Cite This Page:

American Journal of Pathology. "B-Cell Lymphoma Protected By SPAK Silencing." ScienceDaily. ScienceDaily, 10 October 2009. <www.sciencedaily.com/releases/2009/10/091010120627.htm>.
American Journal of Pathology. (2009, October 10). B-Cell Lymphoma Protected By SPAK Silencing. ScienceDaily. Retrieved August 22, 2014 from www.sciencedaily.com/releases/2009/10/091010120627.htm
American Journal of Pathology. "B-Cell Lymphoma Protected By SPAK Silencing." ScienceDaily. www.sciencedaily.com/releases/2009/10/091010120627.htm (accessed August 22, 2014).

Share This




More Health & Medicine News

Friday, August 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Newsy (Aug. 21, 2014) An experimental drug used to treat Marburg virus in rhesus monkeys could give new insight into a similar treatment for Ebola. Video provided by Newsy
Powered by NewsLook.com
Two US Ebola Patients Leave Hospital Free of the Disease

Two US Ebola Patients Leave Hospital Free of the Disease

AFP (Aug. 21, 2014) Two American missionaries who were sickened with Ebola while working in Liberia and were treated with an experimental drug are doing better and have left the hospital, doctors say on August 21, 2014. Duration: 01:05 Video provided by AFP
Powered by NewsLook.com
Cadavers, a Teen, and a Medical School Dream

Cadavers, a Teen, and a Medical School Dream

AP (Aug. 21, 2014) Contains graphic content. He's only 17. But Johntrell Bowles has wanted to be a doctor from a young age, despite the odds against him. He was recently the youngest participant in a cadaver program at the Indiana University NW medical school. (Aug. 21) Video provided by AP
Powered by NewsLook.com
American Ebola Patients Released: What Cured Them?

American Ebola Patients Released: What Cured Them?

Newsy (Aug. 21, 2014) It's unclear whether the American Ebola patients' recoveries can be attributed to an experimental drug or early detection and good medical care. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins